Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody-drug conjugates.

about

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development.Site-Specific Antibody Conjugation for ADC and Beyond.MIgGGly (mouse IgG glycosylation analysis) - a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS

P2860

Q44852748-57533CD9-D45A-4318-AD79-843D45BE25D4 Q55022669-69C9A240-5BE8-43E5-BA1C-F10FC56A5C3E Q58747574-5A8BF78F-E498-40E5-8E6B-52BEF884A2CD

P2860

Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody-drug conjugates.

Item

http://www.wikidata.org/entity/Q47874093

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Chemoenzymatic synthesis of gl ...... ific antibody-drug conjugates.

@en

Chemoenzymatic synthesis of gl ...... ific antibody-drug conjugates.

@nl

type

Item

label

Chemoenzymatic synthesis of gl ...... ific antibody-drug conjugates.

@en

Chemoenzymatic synthesis of gl ...... ific antibody-drug conjugates.

@nl

prefLabel

Chemoenzymatic synthesis of gl ...... ific antibody-drug conjugates.

@en

Chemoenzymatic synthesis of gl ...... ific antibody-drug conjugates.

@nl

P1476

Chemoenzymatic synthesis of gl ...... cific antibody-drug conjugates

@en

P2093

Lai-Xi Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Copper-free click chemistry for dynamic in vivo imaging

Screening a limited structure-based library identifies UDP-GalNAc-specific mutants of alpha-1,3-galactosyltransferase

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose

Optimal Synthetic Glycosylation of a Therapeutic Antibody

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity.

High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity.

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Preparation of well-defined antibody-drug conjugates through glycan remodeling and strain-promoted azide-alkyne cycloadditions.

Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity.

P2888

nprot.2017.058

P304

1702-1721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPROT.2017.058

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wei Huang

Feng Tang

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28749929

http://www.w3.org/2001/XMLSchema#string

P932

5705183

http://www.w3.org/2001/XMLSchema#string

Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody-drug conjugates.

about

P2860

P2860

Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody-drug conjugates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932